- Home
- SISI vs IBIO Comparison
SISI vs IBIO Comparison
Compare SISI & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SISI
- IBIO
- Stock Information
- Founded
- SISI 1997
- IBIO 2008
- Country
- SISI China
- IBIO United States
- Employees
- SISI N/A
- IBIO N/A
- Industry
- SISI Medicinal Chemicals and Botanical Products
- IBIO Biotechnology: Pharmaceutical Preparations
- Sector
- SISI Health Care
- IBIO Health Care
- Exchange
- SISI Nasdaq
- IBIO Nasdaq
- Market Cap
- SISI 14.9M
- IBIO 15.9M
- IPO Year
- SISI 2016
- IBIO N/A
- Fundamental
- Price
- SISI $0.21
- IBIO $0.71
- Analyst Decision
- SISI
- IBIO Strong Buy
- Analyst Count
- SISI 0
- IBIO 3
- Target Price
- SISI N/A
- IBIO $4.87
- AVG Volume (30 Days)
- SISI 5.5M
- IBIO 5.3M
- Earning Date
- SISI 05-15-2025
- IBIO 05-02-2025
- Dividend Yield
- SISI N/A
- IBIO N/A
- EPS Growth
- SISI N/A
- IBIO N/A
- EPS
- SISI N/A
- IBIO N/A
- Revenue
- SISI $9,601,324.00
- IBIO $375,000.00
- Revenue This Year
- SISI N/A
- IBIO $36.00
- Revenue Next Year
- SISI N/A
- IBIO N/A
- P/E Ratio
- SISI N/A
- IBIO N/A
- Revenue Growth
- SISI 1133.26
- IBIO 650.00
- 52 Week Low
- SISI $0.18
- IBIO $0.64
- 52 Week High
- SISI $117.65
- IBIO $6.89
- Technical
- Relative Strength Index (RSI)
- SISI 29.00
- IBIO 37.70
- Support Level
- SISI $0.18
- IBIO $0.68
- Resistance Level
- SISI $0.34
- IBIO $1.04
- Average True Range (ATR)
- SISI 0.05
- IBIO 0.12
- MACD
- SISI -0.01
- IBIO -0.00
- Stochastic Oscillator
- SISI 11.25
- IBIO 7.89
About SISI Shineco Inc.
Shineco Inc aims to care for a healthy life and improve the quality of life by providing safe, efficient, and high-quality health products and services to society. The company has researched and developed various vitro diagnostic reagents and related medical devices to date, and it also produces and sells healthy and nutritious food.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.